May 2016: Hologic (Stock to Study), Gentex (Undervalued)The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Hologic, Inc. (NDQ: HOLX) as its May 2016 "Stock to Study" and Gentex Corporation (NDQ: GNTX) as its May 2016 "Undervalued Stock" for investors' informational and educational use.
"The committee selected Hologic for its performance under a new management team and prospects of ongoing growth in the women's health care field," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee cited Gentex's current reasonable valuation and history of innovation in mirror technologies that will help drive demand."
Check BetterInvesting's May issue for more details about these selections. Go to the trial version of BetterInvesting's online tools to study the investment potential of Hologic and Gentex by viewing their fundamental data and applying judgments.
Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.